These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. IL-13Rα2-bearing, type II NKT cells reactive to sulfatide self-antigen populate the mucosa of ulcerative colitis. Fuss IJ; Joshi B; Yang Z; Degheidy H; Fichtner-Feigl S; de Souza H; Rieder F; Scaldaferri F; Schirbel A; Scarpa M; West G; Yi C; Xu L; Leland P; Yao M; Mannon P; Puri RK; Fiocchi C; Strober W Gut; 2014 Nov; 63(11):1728-36. PubMed ID: 24515806 [TBL] [Abstract][Full Text] [Related]
8. Absence of a role for interleukin-13 in inflammatory bowel disease. Biancheri P; Di Sabatino A; Ammoscato F; Facciotti F; Caprioli F; Curciarello R; Hoque SS; Ghanbari A; Joe-Njoku I; Giuffrida P; Rovedatti L; Geginat J; Corazza GR; MacDonald TT Eur J Immunol; 2014 Feb; 44(2):370-85. PubMed ID: 24338958 [TBL] [Abstract][Full Text] [Related]
9. The role of IL-13 and NK T cells in experimental and human ulcerative colitis. Fuss IJ; Strober W Mucosal Immunol; 2008 Nov; 1 Suppl 1(0 1):S31-3. PubMed ID: 19079225 [TBL] [Abstract][Full Text] [Related]
10. Immune response and inflammatory pathway of ulcerative colitis. Tatiya-Aphiradee N; Chatuphonprasert W; Jarukamjorn K J Basic Clin Physiol Pharmacol; 2018 Dec; 30(1):1-10. PubMed ID: 30063466 [TBL] [Abstract][Full Text] [Related]
11. Biologic therapies against inflammatory bowel disease: a dysregulated immune system and the cross talk with gastrointestinal mucosa hold the key. Dharmani P; Chadee K Curr Mol Pharmacol; 2008 Nov; 1(3):195-212. PubMed ID: 20021434 [TBL] [Abstract][Full Text] [Related]
12. KFL2 participates in the development of ulcerative colitis through inhibiting inflammation via regulating cytokines. Wang ZL; Wang YD; Wang K; Li JA; Li L Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4941-4948. PubMed ID: 30070340 [TBL] [Abstract][Full Text] [Related]
13. CCL25/CCR9 interactions regulate the function of iNKT cells in oxazolone-induced colitis in mice. Zhu S; Bing Y; Wang X; Yu Q; Wang Y; Xu S; Song L; Wang X; Xia B; Zhu Y; Zhou R PLoS One; 2014; 9(6):e100167. PubMed ID: 24936795 [TBL] [Abstract][Full Text] [Related]
14. STAT6 deficiency ameliorates severity of oxazolone colitis by decreasing expression of claudin-2 and Th2-inducing cytokines. Rosen MJ; Chaturvedi R; Washington MK; Kuhnhein LA; Moore PD; Coggeshall SS; McDonough EM; Weitkamp JH; Singh AB; Coburn LA; Williams CS; Yan F; Van Kaer L; Peebles RS; Wilson KT J Immunol; 2013 Feb; 190(4):1849-58. PubMed ID: 23303670 [TBL] [Abstract][Full Text] [Related]
15. Dysregulation of mucosal immune response in pathogenesis of inflammatory bowel disease. Xu XR; Liu CQ; Feng BS; Liu ZJ World J Gastroenterol; 2014 Mar; 20(12):3255-64. PubMed ID: 24695798 [TBL] [Abstract][Full Text] [Related]
17. The functions of type I and type II natural killer T cells in inflammatory bowel diseases. Liao CM; Zimmer MI; Wang CR Inflamm Bowel Dis; 2013 May; 19(6):1330-8. PubMed ID: 23518808 [TBL] [Abstract][Full Text] [Related]
18. Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease. Li J; Ueno A; Fort Gasia M; Luider J; Wang T; Hirota C; Jijon HB; Deane M; Tom M; Chan R; Barkema HW; Beck PL; Kaplan GG; Panaccione R; Qian J; Iacucci M; Gui X; Ghosh S Inflamm Bowel Dis; 2016 Aug; 22(8):1779-92. PubMed ID: 27243594 [TBL] [Abstract][Full Text] [Related]
19. Roles of CD1d-restricted NKT cells in the intestine. van Dieren JM; van der Woude CJ; Kuipers EJ; Escher JC; Samsom JN; Blumberg RS; Nieuwenhuis EE Inflamm Bowel Dis; 2007 Sep; 13(9):1146-52. PubMed ID: 17476670 [TBL] [Abstract][Full Text] [Related]
20. MAIT cells are activated and accumulated in the inflamed mucosa of ulcerative colitis. Haga K; Chiba A; Shibuya T; Osada T; Ishikawa D; Kodani T; Nomura O; Watanabe S; Miyake S J Gastroenterol Hepatol; 2016 May; 31(5):965-72. PubMed ID: 26590105 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]